GENSF Genus plc

USD 28.01 0.00 0
Icon

Genus plc (GENSF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 28.01

0.00 (0.00)%

USD 1.85B

N/A

N/A

N/A

Icon

GENSF

Genus plc (USD)
COMMON STOCK | OTC
USD 28.01
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 1.85B

N/A

USD 28.01

Genus plc (GENSF) Stock Forecast

N/A

Based on the Genus plc stock forecast from 0 analysts, the average analyst target price for Genus plc is not available over the next 12 months. Genus plc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Genus plc is Neutral, which is based on 5 positive signals and 5 negative signals. At the last closing, Genus plc’s stock price was USD 28.01. Genus plc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and -20.27% over the last year.

No recent analyst target price found for Genus plc
No recent average analyst rating found for Genus plc

Company Overview Genus plc

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breedin...Read More

https://www.genusplc.com

Matrix House, Basingstoke, United Kingdom, RG21 4DZ

3,500

June

USD

USA

Adjusted Closing Price for Genus plc (GENSF)

Loading...

Unadjusted Closing Price for Genus plc (GENSF)

Loading...

Share Trading Volume for Genus plc Shares

Loading...

Compare Performance of Genus plc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for GENSF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Genus plc (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S -1.95 (-1.51%) USD599.92B 48.04 5.17

ETFs Containing GENSF

Symbol Name GENSF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Genus plc (GENSF) Stock

Stock Target Advisor's fundamental analysis for Genus plc's stock is Neutral.

GENSF stock's dividend yield is 1.44%. Our analysis grades GENSF stock's dividend yield at D-. This means that GENSF stock's dividend yield is above 60% of the stocks in the Biotechnology sector in the OTC exchange. Based on this GENSF may be a average dividend stock for its sector.

Unfortunately we do not have enough data on GENSF's stock to indicate what its average analyst target is.

GENSF stock's Price/Earning ratio is 43.77. Our analysis grades GENSF stock's Price / Earning ratio at F. This means that GENSF stock's Price/Earning ratio is above 72% of the stocks in the Biotechnology sector in the OTC exchange. Based on this GENSF may be a overvalued for its sector.

The last closing price of GENSF's stock was USD 28.01.

The most recent market capitalization for GENSF is USD 1.85B.

Unfortunately we do not have enough analyst data on GENSF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains Genus plc's stock.

As per our most recent records Genus plc has 3,500 Employees.

Genus plc's registered address is Matrix House, Basingstoke, United Kingdom, RG21 4DZ. You can get more information about it from Genus plc's website at https://www.genusplc.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...